Lascano Danny, Finkelstein Julia B, DeCastro G Joel, McKiernan James M
Herbert Irving Cancer Center, Columbia University College of Physicians and Surgeons, Department of Urology, New York, NY, USA.
J Kidney Cancer VHL. 2015 Apr 4;2(2):45-54. doi: 10.15586/jkcvhl.2015.26. eCollection 2015.
Historically, radical nephrectomy represented the gold standard for the treatment of small (≤ 4cm) as well as larger renal masses. Recently, for small renal masses, the risk of ensuing chronic kidney disease and end stage renal disease has largely favored nephron-sparing surgical techniques, mainly partial nephrectomy. In this review, we surveyed the literature on renal functional outcomes after partial nephrectomy for renal tumors. The largest randomized control trial comparing radical and partial nephrectomy failed to show a survival benefit for partial nephrectomy. With regards to overall survival, surgically induced chronic kidney disease (GFR < 60 ml/min/ 1.73m) caused by nephrectomy might not be as deleterious as medically induced chronic kidney disease. In evaluating patients who underwent donor nephrectomy, transplant literature further validates that surgically induced reductions in GFR may not affect patient survival, unlike medically induced GFR declines. Yet, because patients who present with a renal mass tend to be elderly with multiple comorbidities, many develop a mixed picture of medically, and surgically-induced renal disease after extirpative renal surgery. In this population, we believe that nephron sparing surgery optimizes oncological control while protecting renal function.
从历史上看,根治性肾切除术一直是治疗小(≤4cm)及较大肾肿块的金标准。最近,对于小肾肿块,继发慢性肾脏病和终末期肾病的风险在很大程度上支持保留肾单位的手术技术,主要是部分肾切除术。在本综述中,我们查阅了有关肾肿瘤部分肾切除术后肾功能结果的文献。比较根治性肾切除术和部分肾切除术的最大规模随机对照试验未能显示部分肾切除术有生存获益。关于总生存期,肾切除术所致的手术性慢性肾脏病(肾小球滤过率<60ml/min/1.73m²)可能不像药物性慢性肾脏病那样有害。在评估接受供体肾切除术的患者时,移植文献进一步证实,与药物性肾小球滤过率下降不同,手术导致的肾小球滤过率降低可能不会影响患者生存。然而,由于出现肾肿块的患者往往年事已高且有多种合并症,许多患者在肾切除术后会出现药物性和手术性肾病的混合情况。在这一人群中,我们认为保留肾单位手术在优化肿瘤控制的同时保护了肾功能。